Qualitative Exploration of Head & Neck Cancer Patient Reported Experience of Radiotherapy
H&NPRER-RAC
1 other identifier
observational
20
1 country
1
Brief Summary
The study aims to explore the experience of patients with Head and Neck Cancer, who are preparing for and/or completed radiotherapy treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 30, 2020
CompletedFirst Posted
Study publicly available on registry
September 9, 2020
CompletedStudy Start
First participant enrolled
May 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedMarch 14, 2023
March 1, 2023
2.3 years
July 30, 2020
March 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient experience
Interviews will be used to generate themes that capture the patients experience. These themes are the primary outcome.There are no units of measurement or data collection tools only an interview schedule.
within 6 weeks of using a mask
Secondary Outcomes (1)
potential items for a questionnaire
2 months after completing or partially completing radiotherapy.
Study Arms (2)
Stage 1
20 patients will be interviewed once, which will be approximately 60 minutes in duration. The interviews will be audio recorded.
Stage 2
Five patients who participated in stage 1 will take part in a cognitive interview, which will be approximately 60 minutes in duration.The interviews will be audio recorded.
Interventions
Eligibility Criteria
Range of patients who have completed or partially completed radiotherapy treatment utilising a mask. This will include a range of patients (i) those who's records indicate, or patients report that they experienced severe difficulties tolerating the mask, (ii) those who could not complete the full course of radiotherapy; and (iii) those who experienced no difficulties at all.
You may qualify if:
- Aged over 18 (no upper age limit)
- Completed or partially completed radiotherapy treatment utilising a mask ≥ 6 weeks previous to study entry
You may not qualify if:
- Unable to understand and communicate in the English language
- Unable to provide written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Christie NHS Foundation
Manchester, m20 4bx, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jacqui Stringer
The Christie NHS Foundation Trust
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 30, 2020
First Posted
September 9, 2020
Study Start
May 5, 2021
Primary Completion
September 1, 2023
Study Completion
September 1, 2023
Last Updated
March 14, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share